{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:08:32Z","timestamp":1789513712165,"version":"build-2803163510"},"reference-count":53,"publisher":"The Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8,1]]},"DOI":"10.1210\/jc.2010-0856","type":"journal-article","created":{"date-parts":[[2010,8,4]],"date-time":"2010-08-04T22:40:58Z","timestamp":1280961658000},"page":"3569-3577","source":"Crossref","is-referenced-by-count":135,"title":["Update on Estrogens and the Skeleton"],"prefix":"10.1210","volume":"95","author":[{"given":"Sundeep","family":"Khosla","sequence":"first","affiliation":[{"name":"Endocrine Research Unit, College of Medicine, Mayo Clinic, Rochester, Minnesota 55905"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113325481400_R1","first-page":"298","article-title":"Post-menopausal osteoporosis.","volume":"55","author":"Albright","year":"1940","journal-title":"Trans Assoc Am Physicians"},{"key":"key\n\t\t\t\t2019041113325481400_R2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7326\/0003-4819-122-1-199501010-00002","article-title":"Estrogen replacement therapy and fractures in older women.","volume":"122","author":"Cauley","year":"1995","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019041113325481400_R3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial.","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113325481400_R4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00404-007-0442-1","article-title":"Long-term impact of the women\u2019s health initiative on HRT.","volume":"277","author":"Parente","year":"2008","journal-title":"Arch Gynecol Obstet"},{"key":"key\n\t\t\t\t2019041113325481400_R5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1210\/jc.2009-1740","article-title":"Update in male osteoporosis.","volume":"95","author":"Khosla","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113325481400_R6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1210\/edrv.23.3.0465","article-title":"Sex steroids and the construction and conservation of the adult skeleton.","volume":"23","author":"Riggs","year":"2002","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041113325481400_R7","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1210\/en.2003-0892","article-title":"Low estrogen and high parathyroid hormone-related peptide levels contribute to accelerated bone resorption and bone loss in lactating mice.","volume":"144","author":"VanHouten","year":"2003","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t2019041113325481400_R8","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1001\/jama.1996.03540070045029","article-title":"Elevated parathyroid hormone-related peptide associated with lactation and bone density loss.","volume":"276","author":"Sowers","year":"1996","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113325481400_R9","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2007.07.025","article-title":"Estrogen prevents bone loss via estrogen receptor \u03b1 and induction of fas ligand in osteoclasts.","volume":"130","author":"Nakamura","year":"2007","journal-title":"Cell"},{"key":"key\n\t\t\t\t2019041113325481400_R10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1210\/me.2009-0354","article-title":"The estrogen receptor-\u03b1 in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone.","volume":"24","author":"Martin-Millan","year":"2010","journal-title":"Mol Endocrinol"},{"key":"key\n\t\t\t\t2019041113325481400_R11","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1074\/jbc.M411530200","article-title":"Transient versus sustained phosphorylation and nuclear accumulation of ERKs underlie anti- versus pro-apoptotic effects of estrogens.","volume":"280","author":"Chen","year":"2005","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041113325481400_R12","first-page":"3128","article-title":"The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone.","volume":"82","author":"Tomkinson","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113325481400_R13","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1172\/JCI10942","article-title":"Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men.","volume":"106","author":"Falahati-Nini","year":"2000","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113325481400_R14","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/ajcn\/67.4.693","article-title":"A longitudinal study of calcium homeostasis during human pregnancy and lactation and after resumption of menses.","volume":"67","author":"Ritchie","year":"1998","journal-title":"Am J Clin Nutr"},{"key":"key\n\t\t\t\t2019041113325481400_R15","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1359\/jbmr.070207","article-title":"Effect of blockade of TNF-a and interleukin-1 action on bone resorption in early postmenopausal women.","volume":"22","author":"Charatcharoenwitthaya","year":"2007","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113325481400_R16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1210\/er.2007-0014","article-title":"Receptor activator of nuclear factor \u03baB ligand and osteoprotegerin regulation of bone remodeling in health and disease.","volume":"29","author":"Kearns","year":"2008","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041113325481400_R17","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI200317215","article-title":"Role of RANK ligand in mediating increased bone resorption in early postmenopausal women.","volume":"111","author":"Eghbali-Fatourechi","year":"2003","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113325481400_R18","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1172\/JCI1039","article-title":"Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow.","volume":"101","author":"Jilka","year":"1998","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113325481400_R19","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1172\/JCI28550","article-title":"Estrogen deficiency and bone loss: an inflammatory tale.","volume":"116","author":"Weitzmann","year":"2006","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113325481400_R20","first-page":"115","article-title":"Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis.","volume":"21","author":"Manolagas","year":"2000","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041113325481400_R21","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: similarities and differences and their potential influences on clinical efficacy.","volume":"19","author":"Russell","year":"2008","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t2019041113325481400_R22","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.bone.2006.10.014","article-title":"The antioxidant effect of estrogen and selective estrogen receptor modulators in the inhibition of osteocyte apoptosis in vitro.","volume":"40","author":"Mann","year":"2007","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041113325481400_R23","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.bone.2007.03.017","article-title":"Molecular and cellular mechanisms of the anabolic effect of intermittent PTH.","volume":"40","author":"Jilka","year":"2007","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041113325481400_R24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1172\/JCI33612","article-title":"Building bone to reverse osteoporosis and repair fractures.","volume":"118","author":"Khosla","year":"2008","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113325481400_R25","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis.","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113325481400_R26","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1359\/jbmr.2002.17.1.172","article-title":"Role of low levels of endogenous estrogen in regulation of bone resorption in late postmenopausal women.","volume":"17","author":"Heshmati","year":"2002","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113325481400_R27","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.berh.2009.09.003","article-title":"Hormonal deprivation therapy-induced osteoporosis in postmenopausal women with breast cancer.","volume":"23","author":"Ghazi","year":"2009","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"key\n\t\t\t\t2019041113325481400_R28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","article-title":"Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years\u2019 adjuvant treatment for breast cancer.","volume":"365","author":"Howell","year":"2005","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041113325481400_R29","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1200\/JCO.2007.11.0726","article-title":"Effect of anastrozole on bone mineral density: 5-year results from the Anastrozole, Tamoxifen, Alone or in Combination Trial 18233230.","volume":"26","author":"Eastell","year":"2008","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2019041113325481400_R30","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa032312","article-title":"A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.","volume":"349","author":"Goss","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113325481400_R31","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1200\/JCO.2005.05.4882","article-title":"Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA. 17.","volume":"24","author":"Perez","year":"2006","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2019041113325481400_R32","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1200\/JCO.2006.08.8617","article-title":"Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1\u201398.","volume":"25","author":"Coates","year":"2007","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2019041113325481400_R33","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1200\/JCO.2005.07.097","article-title":"Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer.","volume":"23","author":"L\u00f8nning","year":"2005","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2019041113325481400_R34","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa040331","article-title":"A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.","volume":"350","author":"Coombes","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113325481400_R35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1470-2045(07)70003-7","article-title":"Skeletal effects of exemestane on bone-mineral density, bone, biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study.","volume":"8","author":"Coleman","year":"2007","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t2019041113325481400_R36","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1056\/NEJM199203263261302","article-title":"Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer.","volume":"326","author":"Love","year":"1992","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113325481400_R37","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1200\/JCO.2003.08.017","article-title":"American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer.","volume":"21","author":"Hillner","year":"2003","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2019041113325481400_R38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.maturitas.2009.07.008","article-title":"Prevention of osteoporosis after breast cancer.","volume":"64","author":"Reid","year":"2009","journal-title":"Maturitas"},{"key":"key\n\t\t\t\t2019041113325481400_R39","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1001\/jama.290.8.1042","article-title":"Ultralow-dose micronized 17\u03b2-estradiol and bone density and bone metabolism in older women: a randomized controlled trial.","volume":"290","author":"Prestwood","year":"2003","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113325481400_R40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-117-1-1","article-title":"Treatment of postmenopausal osteoporosis with transdermal estrogen.","volume":"117","author":"Lufkin","year":"1992","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019041113325481400_R41","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/01.AOG.0000137833.43248.79","article-title":"Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial.","volume":"104","author":"Ettinger","year":"2004","journal-title":"Obstet Gynecol"},{"key":"key\n\t\t\t\t2019041113325481400_R42","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMe0905480","article-title":"Increasing options for the treatment of osteoporosis.","volume":"361","author":"Khosla","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113325481400_R43","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/en.2003-0900","article-title":"Mining the complexities of the estrogen signaling pathways for novel therapeutics.","volume":"144","author":"McDonnell","year":"2003","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t2019041113325481400_R44","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1073\/pnas.0808742106","article-title":"The transactivating function 1 of estrogen receptor \u03b1 is dispensable for the vasculoprotective actions of 17\u03b2-estradiol.","volume":"106","author":"Billon-Gale\u0301s","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019041113325481400_R45","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00198-005-2030-1","article-title":"Anti-vertebral fracture efficacy of raloxifene: a meta-analysis.","volume":"17","author":"Seeman","year":"2006","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t2019041113325481400_R46","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113325481400_R47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa062462","article-title":"Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women.","volume":"355","author":"Barrett-Connor","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113325481400_R48","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1517\/14656560903575662","article-title":"Developing drugs to treat osteoporosis: lessons learned?","volume":"11","author":"Paula","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"key\n\t\t\t\t2019041113325481400_R49","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1210\/jc.2008-2143","article-title":"Effects of arzoxifene on bone mineral density and endometrium in postmenopausal women with normal or low bone mass.","volume":"94","author":"Bolognese","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113325481400_R50","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1056\/NEJMoa0808692","article-title":"Lasofoxifene in postmenopausal women with osteoporosis.","volume":"362","author":"Cummings","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113325481400_R51","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.fertnstert.2009.02.093","article-title":"Efficacy of tissue-selective estrogen complex of bazedoxifene\/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women.","volume":"92","author":"Lindsay","year":"2009","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041113325481400_R52","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.fertnstert.2009.03.113","article-title":"Evaluation of bazedoxifene\/conjugated estrogens for the treatment of menopausal systems and effects on metabolic parameters and overall safety profile.","volume":"92","author":"Lobo","year":"2009","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041113325481400_R53","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1138\/20070275","article-title":"Estrogen and the death of osteoclasts: a fascinating story.","volume":"4","author":"Khosla","year":"2007","journal-title":"BoneKEy-Osteovision"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/95\/8\/3569\/9066347\/jcem3569.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T08:58:40Z","timestamp":1559379520000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/95\/8\/3569\/2596388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,1]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2010-0856","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,1]]}}}